secwatch / observer
8-K filed August 2, 2023, 7:59 PM ET ticker CCRN CIK 0001141103
earnings confidence high sentiment negative materiality 0.75

Cross Country Healthcare Q2 revenue down 28% YoY; guides Q3 lower

CROSS COUNTRY HEALTHCARE INC

2023-Q2 EPS reported $1.41 revenue$1,163,402,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CROSS COUNTRY HEALTHCARE INC reported the quarter ended June 30, 2023 results: revenue $540.7 million, net income $21.3 million, EPS $0.60. Guidance initiated.

Period
the quarter ended June 30, 2023
Revenue
$540.7 million
Net income
$21.3 million
EPS
$0.60
Guidance
initiated
Result
reported results
Exact text from the filing
clients to optimize their workforce, and to further improve our profitability as we continue to penetrate the vendor neutral space.” Second quarter consolidated revenue was $540.7 million, a decrease of 28% year-over-year and 13% sequentially. Consolidated gross profit margin was 22.8%, up 20 basis points year-over-year and 40 basis points sequentially. Net
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CROSS COUNTRY HEALTHCARE INC reported the six months ended June 30, 2023 results: revenue $1.2 billion, net income $50.8 million, EPS $1.41. Guidance initiated.

Period
the six months ended June 30, 2023
Revenue
$1.2 billion
Net income
$50.8 million
EPS
$1.41
Guidance
initiated
Result
reported results
Exact text from the filing
For the six months ended June 30, 2023, consolidated revenue was $1.2 billion, a decrease of 25% year-over-year.
View on SEC.gov

Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR
accession 0001157523-23-001230
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.